ArticleKorean circulation journal2019

Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea.

Gyu Hur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.